Trial Profile

Proof of Concept Clinical Trial of Gene Therapy GVB-2001 Delivered Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma

Status: Recruiting

Phase of Trial: Phase I/II

Latest Information Update: 13 Jan 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs IVW 2001 (Primary)
Indications Open-angle glaucoma
Focus Adverse reactions; Proof of concept; Therapeutic Use
Sponsors iView Therapeutics

Most Recent Events

18 Dec 2025 According to IVIEW Therapeutics Inc. media release, the company has successfully completed treatment of the first patient with primary open-angle glaucoma (POAG).
02 Jul 2025 Planned initiation date changed from 30 Jun 2025 to 1 Oct 2025.
02 Jul 2025 Status changed from not yet recruiting to recruiting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com